Literature DB >> 28733789

Is That Possible to Stop or Cease the NASH to Turn into HCC?

Ahmet Uygun1.   

Abstract

Year:  2017        PMID: 28733789     DOI: 10.1007/s12029-017-9961-6

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  52 in total

Review 1.  Genetic polymorphisms and oxidative stress in non-alcoholic steatohepatitis (NASH): A mini review.

Authors:  Claudia P Oliveira; Jose Tadeu Stefano
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-07-06       Impact factor: 2.947

2.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

3.  Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

Authors:  Paolo Sorrentino; Salvatore D'Angelo; Umberto Ferbo; Pietro Micheli; Alessandra Bracigliano; Raffaela Vecchione
Journal:  J Hepatol       Date:  2008-11-14       Impact factor: 25.083

4.  Excess risk of primary liver cancer in patients with diabetes mellitus.

Authors:  H O Adami; W H Chow; O Nyrén; C Berne; M S Linet; A Ekbom; A Wolk; J K McLaughlin; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1996-10-16       Impact factor: 13.506

Review 5.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

Review 6.  The gut microbiota and obesity: from correlation to causality.

Authors:  Liping Zhao
Journal:  Nat Rev Microbiol       Date:  2013-08-05       Impact factor: 60.633

7.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

8.  Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis.

Authors:  Yoko Takaki; Yoshimasa Saito; Azusa Takasugi; Kohta Toshimitsu; Shoji Yamada; Toshihide Muramatsu; Masaki Kimura; Kazuo Sugiyama; Hiromu Suzuki; Eri Arai; Hidenori Ojima; Yae Kanai; Hidetsugu Saito
Journal:  Cancer Sci       Date:  2014-09-25       Impact factor: 6.716

9.  Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Authors:  Pauliina Pisto; Merja Santaniemi; Risto Bloigu; Olavi Ukkola; Y Antero Kesäniemi
Journal:  BMJ Open       Date:  2014-03-20       Impact factor: 2.692

10.  Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.

Authors:  Veronika Fedirko; Talita Duarte-Salles; Christina Bamia; Antonia Trichopoulou; Krasimira Aleksandrova; Dimitrios Trichopoulos; Elisabeth Trepo; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Marina Kvaskoff; Tilman Kühn; Annie Lukanova; Heiner Boeing; Brian Buijsse; Eleni Klinaki; Chrysanthi Tsimakidi; Alessio Naccarati; Giovanna Tagliabue; Salvatore Panico; Rosario Tumino; Domenico Palli; H Bas Bueno-de-Mesquita; Peter D Siersema; Petra H Peters; Eiliv Lund; Magritt Brustad; Karina Standahl Olsen; Elisabete Weiderpass; Raul Zamora-Ros; María-José Sánchez; Eva Ardanaz; Pilar Amiano; Carmen Navarro; J Ramón Quirós; Mårten Werner; Malin Sund; Björn Lindkvist; Johan Malm; Ruth C Travis; Kay-Tee Khaw; Magdalena Stepien; Augustin Scalbert; Isabelle Romieu; Pagona Lagiou; Elio Riboli; Mazda Jenab
Journal:  Hepatology       Date:  2014-08-28       Impact factor: 17.425

View more
  1 in total

1.  Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Sana Raza; Sangam Rajak; Baby Anjum; Rohit A Sinha
Journal:  Hepatoma Res       Date:  2019-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.